Chr. Hansen has a significant position in manufacture and distribution of Dairy
Cultures. For the reasons set out in Section 5.4.2, the Commission found that the Transaction would not give the merged entity the ability or incentive to leverage enzymes to sell dairy cultures. This was also confirmed by a majority of 300 Non-confidential minutes with a distributor, 1 June 2023, 15:00 – 16:00 CET. 301 eRFI to customers, reply to Question H.1. 302 eRFI to customers, reply to Question H.1. 303 eRFI to customers, reply to Question H.1. 304 Non-confidential minutes, call with customer, 3 May 2023, 16:00 – 17:00 CET. 305 eRFI to customers, reply to Question H.3. 306 eRFI to customers, reply to Question H.3. respondents to the market investigation specifically in relation to dairy cultures.
As a customer explained: “[i]n terms of sourcing products as a package or a bundle, [customer] explained that lactase and other ingredients (cultures and enzymes) are purchased separately. […] The food ingredient market, namely cultures and enzymes, is not prone to bundling due to its complexity”.308 The majority of responding competitors replied that it is not common to develop dairy enzymes so that they work better or only work with certain specific dairy cultures.
309 Moreover, the majority of responding end-customers also considered that there would be other sources of supply to match the merged entity’s bundled offers.310 5.5. Innovation